By staff writers
March 6, 2013

Breast density software developer Matakina International is highlighting five abstracts to be presented at the upcoming ECR 2013 in Vienna that show that the company's Volpara objective breast density measurement software helps overcome the limitations of mammography for women with dense breasts.

The abstracts include the following:

  • C-1033, from Dr. Gisella Gennaro of the Veneto Institute of Oncology in Padua, Italy
  • C-1770 and C-1762, from Ralph Highnam, PhD, CEO of Matakina International
  • C-1953, from Dr. Nico Karssemeijer of Radboud University Medical Centre in Nijmegen, the Netherlands
  • C-1787, from Dr. Kwan Ng of the University of Malaya in Kuala Lumpur, Malaysia

In other Matakina news, Volpara has been chosen for use in the European Union collaborative Adapting Breast Cancer Screening Strategy Using Personalized Risk Estimation (ASSURE) research project, the company said.

Matakina will participate in EU breast cancer research
Breast density software developer Matakina International has revealed its Volpara breast density measurement software will be used in the European Union's...
Matakina partners with Microsoft, offers cloud-based Volpara
Breast density software company Matakina International announced a new partnership with Microsoft to make its Volpara breast density assessment software...
Matakina names Europe, Asia sales execs
New Zealand breast imaging software developer Matakina International has appointed Laurence Veron and Don Alvarez to lead its European and Asian sales...
Matakina participates in Dutch breast screening MRI trial
New Zealand breast imaging software developer Matakina International has announced that the Dutch breast screening organizations and the University Medical...
Sectra signs deal with Matakina
PACS firm Sectra announced it has signed an agreement with Matakina International to distribute Matakina's Volpara breast density software integrated...

Copyright © 2013

Last Updated hh 3/6/2013 3:51:58 PM